Stay updated on Enzyme Pricing
Sign up to get notified when there's something new on the Enzyme Pricing page.

Latest updates to the Enzyme Pricing page
- Check2 days agoChange DetectedA testimonial from Subtle Medical CEO Enhao Gong appears in the customer-endorsement section, praising Enzyme’s quality-process and post-market compliance support.SummaryDifference1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA banner announces that Enzyme has been acquired by Greenlight Guru and directs visitors to learn more.SummaryDifference2%

- Check23 days agoChange DetectedThe pricing page now features Diego Rey of Endpoint Health describing the improvement in its QMS process with Enzyme, replacing a testimonial from Enhao Gong of Subtle Medical. The Enzyme acquisition notice for Greenlight Guru has also been removed.SummaryDifference2%

- Check30 days agoChange DetectedThe plans page replaces Endpoint Health’s testimonial from Diego Rey with Subtle Medical’s endorsement from CEO Enhao Gong, highlighting Enzyme’s quality-process and post-market compliance support.SummaryDifference0.6%

- Check44 days agoChange DetectedThe Plans page no longer includes a reference to Endpoint Health, the Chief Scientific Officer's name, or a customer testimonial. These removals reduce branding cues and social proof that support trust and context around the Core, Premarket, and Postmarket plans.SummaryDifference0.6%

- Check51 days agoChange DetectedAdds Subtle Medical as a client, lists Enhao Gong as CEO, and includes a testimonial about Enzyme's impact on quality processes and post-market compliance. This strengthens social proof and contextual relevance on the Plans page.SummaryDifference0.6%

Stay in the know with updates to Enzyme Pricing
Enter your email address, and we'll notify you when there's something new on the Enzyme Pricing page.